. Show Affiliations »
Abstract
Mesh： See more » Antineoplastic Agents/economicsAntineoplastic Agents/therapeutic useBenzenesulfonates/economicsBenzenesulfonates/therapeutic useCarcinoma, Hepatocellular/drug therapyCost-Benefit AnalysisDrug Industry/economicsFees, PharmaceuticalHumansLiver Neoplasms/drug therapyNiacinamide/analogs & derivativesPhenylurea CompoundsPyridines/economicsPyridines/therapeutic useSorafenib
Substances： See more » Antineoplastic AgentsBenzenesulfonatesPhenylurea CompoundsPyridinesNiacinamideSorafenib
Year: 2009 PMID： 19944844 DOI： 10.1016/S0140-6736(09)62045-6
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321